Related Experiment Videos
Should anticancer drug doses be adjusted in the obese patient?
Journal of the National Cancer Institute
|March 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.
British journal of cancer·2017
Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.
Clinical and translational science·2017
Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide.
Clinical and translational science·2017
ABCC4 Is a Determinant of Cytarabine-Induced Cytotoxicity and Myelosuppression.
Clinical and translational science·2016
Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia.
Clinical pharmacology and therapeutics·2015
Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.
Journal of the National Cancer Institute·2026
Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.
Journal of the National Cancer Institute·2026
Pharmacogenetic variants in the molecular characterization initiative: a report from the children's oncology group.
Journal of the National Cancer Institute·2026
Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.
Journal of the National Cancer Institute·2026
Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.
Journal of the National Cancer Institute·2026